Text Size

Effect of Bran Fiber Type on Subjective and Objective Measures of Appetite

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:
NCT01560000
First received: March 5, 2012
Last updated: March 13, 2013
Last verified: March 2013
History of Changes
  Purpose

The objective of this study is to determine the satiety value of different bran fibers on appetite & subsequent food intake with acute consumption. Satiety will be measured subjectively by visual analogue scales (VAS).


Condition Intervention
Food
 Dietary Supplement: Dietary fiber

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Prevention
Official Title: Effect of Bran Fiber Type on Subjective and Objective Measures of Appetite

Resource links provided by NLM:

MedlinePlus related topics: Dietary Fiber
U.S. FDA Resources

Further study details as provided by University of Minnesota - Clinical and Translational Science Institute:

Primary Outcome Measures:
  • Satiety response [ Time Frame: 4 hours ] [ Designated as safety issue: No ]

Enrollment: 40
Study Start Date: March 2012
Study Completion Date: December 2012
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
fiber Dietary Supplement: Dietary fiber
Wheat, barley, oat and bran fibers added to a breakfast product

Detailed Description:

Visual analogue scales will be used to measure satiety at 15, 30 45, 60, 120, 180, and 240 minutes

  Eligibility

Ages Eligible for Study:   18 Years to 40 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy women between the ages of 18-40
  • body mass index between 18.5-29.9kg/m2
  • eat breakfast regularly
  • nonsmoking
  • not taking weight loss medications
  • non-dieting (weight stable over the past 3 months)
  • spoken and written English literacy.

Exclusion Criteria:

  • antibiotic use within the past 6 months
  • cardiovascular disease
  • diabetes mellitus
  • cancer in the past 5 years
  • renal or hepatic disease
  • recent bacterial infection
  • gastrointestinal conditions affecting digestion or absorption
  • weight loss>5kg in prior 3 months (intentional or unintentional)
  • history of drug or alcohol abuse in prior 6 months
  • food allergies
  • high fiber intake(3 or more servings of high fiber foods per day)
  • lipid-lowering, anti-hypertensive or anti-inflammatory steroid medication use
  • restrained eater(score>10 on the dietary restraint factor of the Three Factor Eating Questionnaire)
  • concurrent or recent (within 30 days) participation in an intervention study.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01560000

Locations
United States, Minnesota
University of Minnesota
Saint Paul, Minnesota, United States, 55108
Sponsors and Collaborators
University of Minnesota - Clinical and Translational Science Institute
Investigators
Principal Investigator: Joanne Slavin, PhD University of Minnesota - Clinical and Translational Science Institute
  More Information

No publications provided

Responsible Party: University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier: NCT01560000     History of Changes
Other Study ID Numbers: 1202E10321
Study First Received: March 5, 2012
Last Updated: March 13, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of Minnesota - Clinical and Translational Science Institute:
The focus of this study is to determine satiety

ClinicalTrials.gov processed this record on May 23, 2013